health
Novo Nordisk Set to Stop Supply of a Key Diabetic Drug, Indian Patients Urge WHO, Govt to Intervene
Novo Nordisk is phasing out pens of the human form of insulin. In India and some African nations, human insulin pens are cheaper than analogue insulin and preferred over it.